Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36(2):451–5.

Article  PubMed  Google Scholar 

Bjornsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419–25 (25 e1-3; quiz e19-20).

Article  PubMed  Google Scholar 

Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, et al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019 Jun;156(8):2230-41 e11.

De Valle MB, Av Klinteberg V, Alem N, Olsson R, Bjornsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24(8):1187–95.

Article  PubMed  Google Scholar 

de Abajo FJ, Montero D, Madurga M, Garcia Rodriguez LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol. 2004;58(1):71–80.

Article  PubMed  PubMed Central  Google Scholar 

Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol. 2012;107(9):1380–7.

Article  PubMed  Google Scholar 

Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016;14:10.

Article  PubMed  PubMed Central  Google Scholar 

Reuben A, Koch DG, Lee WM, Acute Liver Failure Study G. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52(6):2065–76.

Article  PubMed  Google Scholar 

Wei G, Bergquist A, Broome U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med. 2007;262(3):393–401.

Article  CAS  PubMed  Google Scholar 

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340–52.

Article  PubMed  Google Scholar 

Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug-induced liver injury network (DILIN) prospective study. Drug Saf. 2009;32(1):55–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Machlin SR. Design, methods, and field results of the 1996 medical expenditure panel survey, medical provider component: US Department of Health and Human Services, Public Health Service, Agency; 2000.

Rockey DC, Seeff LB, Rochon J, Freston J, Chalasani N, Bonacini M, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010;51(6):2117–26.

Article  PubMed  Google Scholar 

Zuvekas SH, Kashihara D. The impacts of the COVID-19 pandemic on the medical expenditure panel survey. Am J Public Health. 2021;111(12):2157–66.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki A, Tillmann H, Williams J, Hauser RG, Frund J, Suzuki M, et al. Assessment of the frequency, phenotypes, and outcomes of acute liver injury associated with amoxicillin/clavulanate in 1.4 million patients in the veterans health administration. Drug Saf. 2023;46(2):129–43.

Article  CAS  PubMed  Google Scholar 

Gu S, Rajendiran G, Forest K, Tran TC, Denny JC, Larson EA, et al. Drug-induced liver injury with commonly used antibiotics in the all of us research program. Clin Pharmacol Ther. 2023;114(2):404–12.

Article  CAS  PubMed  Google Scholar 

Torgersen J, Mezochow AK, Newcomb CW, Carbonari DM, Hennessy S, Rentsch CT, et al. Severe acute liver injury after hepatotoxic medication initiation in real-world data. JAMA Intern Med. 2024;184(8):943–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Björnsson ES. Global epidemiology of drug-induced liver injury (DILI). Current Hepatology Reports. 2019;18(3):274–9.

Article  Google Scholar 

Li X, Tang J, Mao Y. Incidence and risk factors of drug-induced liver injury. Liver Int. 2022;42(9):1999–2014.

Article  PubMed  Google Scholar 

Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe’er I, Floratos A, et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 2009;41(7):816–9.

Article  CAS  PubMed  Google Scholar 

Urban TJ, Nicoletti P, Chalasani N, Serrano J, Stolz A, Daly AK, et al. Minocycline hepatotoxicity: clinical characterization and identification of HLA-B *35:02 as a risk factor. J Hepatol. 2017;67(1):137–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nicoletti P, Aithal GP, Bjornsson ES, Andrade RJ, Sawle A, Arrese M, et al. Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study. Gastroenterology. 2017;152(5):1078–89.

Article  CAS  PubMed  Google Scholar